Clinical Trial Update: Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority trial in Brazil evaluating two inhaled combination therapies for moderate asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide/Formoterol (budesonide/formoterol)
• Fluticasone/formoterol (Alenia) (Formoterol + Fluticasone)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Moderate Asthma | Phase 3 | Status: WITHDRAWN